The Zacks Analyst Blog shows Novo Nordisk, Honeywell International and American Tower

Chicago, IL – May 7, 2025 – Zacks.com announces the list of shares presented in the analyst blog. Every day, the analysts of Zacks Equity Research discuss the latest news and events that affect stocks and financial markets. The shares recently presented on the blog include: Novo Nordisk A/S NVO, Honeywell International Inc. and American Tower Corp. Government office.

Here are highlights from the analyst blog on Tuesday:

The Zacks Research Daily presents the best research production of our team of analysts. Today's research offers new research reports over 16 important shares, including Novo Nordisk A/S, Honeywell International Inc. and American Tower Corp. These research reports were raised from the approximately 70 reports that were published by our analyst team today.

You can Here you can find all today's research reports here >>>

In front of the Wall Street

The daily article “Vor Wall Street” is a must for all investors who want to be ready for the trade campaign of this day. The article appears before the market opens and tries to understand the economic publications of this morning and how they will influence the market campaign of this day. You can read this article on our homepage free of charge and actually register there to get an e -mail notification because this article comes out every morning.

You can read today's AWS >>> Pre-markets slide in the record trade deficit, the result of the first quarter

The research reports presented today

Shares of Novo Nordisk The Zacks Large Cap Pharmaceutical Industry have below average last year (-44.9% compared to -6.9%). The company's failure to achieve the weight loss goal with Cagrisema twice led to Novo Nordisk a big setback. An intensive rivalry in the obesity sector also threatens its market share. Patent run and price pressure via the diabetes market remain a headwind.

Nevertheless, the diabetes drugs from Novo Nordisk are Ozempic and Rybelsus and obesity. Label extensions in cardiovascular and other indications will probably increase sales. The Wegovy offer restrictions have tackled by making serious investments to increase production.

It is now indicated in the USA and the EU to also reduce heart risks, which is a big boost. Novo Nordisk also pursues other indications such as liver fibrosis and mash for Semaglutid.

(You can Read the full research report about Novo Nordisk >>> here)))

HoneywellsThe stocks exceeded the Zacks diversified operations industry last year ( +11.2% compared to +8.3%). The strength of the company in commercial aviation and construction automation is good for Honeywell. The air and space segment is particularly strong, which is powered by strength in the defense business and the growth of air traffic times.

The segment contributes the strong demand in the entire business with the commercial aviation aftermarket. The company continues to reward shareholders, which increases the appeal of the share. While acquisitions have expanded the product range and the geographical reach, they have also increased the company's balance sheet debt.

However, the weakness in the segment of industrial automation due to the lower demand for intelligent energy and thermal solutions is worrying. The weakened demand for personal protective equipment within the business technologies for detection and security technologies also affects. Foreign currency translation remains an overhang.

(You can Read the full research report about Honeywell >>> here)))

Shares of American tower have exceeded the Zacks Riding and Equity Trust – another industry last year ( +27.5% compared to +13.9%). The company has an extensive, geographically diversified real estate portfolio. The results of the first quarter of 2025 reflect an increase in revenue, which is cited by the sales growth of real estate and service segments.

Since the wireless airlines increase the investment expenses due to the increasing wireless penetration, the accelerated of 5G network processing efforts and spectrum auctions, demand is likely to remain strong. The long -term rental contracts with its tenants insure stable cash flows. The continued efforts of Macro Tower Investments to expand your global footprint and satisfy the demand in these markets are good for long-term growth.

A decent financial position supports your growth results. However, customer concentration and consolidation are a problem in the wireless industry and will probably weigh the top line growth. It is also exposed to a headwind from sprint emigration.

(You can Read the full research report about the American Tower >>> here)))

Why didn't you look at the top shares of Zacks?

Since 2000, our top bearing strategies have flipped up with the average profit of S&P +7.7% per year. Surprisingly, they rose with average profit from +48.4%, +50.2% And +56.7% per year.

Today you can access your live picks without any costs or obligation.

See shares for free >>

Media contact

Zacks Investment Research

800-767-3771 Ext. 9339

Support@zacks.com

The performance in the past is not a guarantee of future results. Inherent with an investment is the loss of loss. This material is only provided for information purposes, and nothing is investments, legal, accounting or tax advice or a recommendation to buy, sell or maintain security. There is no recommendation or advice whether an investment is suitable for a specific investor. It should not be assumed that investments in securities, companies, sectors or markets that have been identified and described were or become profitable. All information is current at the time of the current date and can be changed without prior notice. All expressed views or opinions may not reflect that of the entire company. Zack's Investment Research does not participate in investment banking, market manufacturing or asset management activities of securities. These returns come from hypothetical portfolios, which consist of shares with Zacks rank = 1, which were reproduced monthly with zero transaction costs. These are not the returns of the actual stock portfolios. The S&P 500 is a non -managed index. Visit /Performance for information on the performance numbers shown in this press release.

Would you like the latest recommendations from Zack's Investment Research? Today you can download 7 best stocks for the next 30 days. Click here to receive this free report

American Tower Corporation (office): Report on free stock analysis

Honeywell International Inc. (Hon): Free stock analysis report

Novo Nordisk A/S (NVO): Free stock analysis report

This article was originally published in Zack's Investment Research (Zacks.com).

Zacks Investment Research

Leave a Comment Cancel reply